BSX vs RBRK · P/E 20, rev $10.65B vs rev $1.32B
Boston Scientific Corp (BSX) versus Rubrik, Inc. (RBRK) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Rubrik, Inc. (RBRK) is a software - infrastructure company listed on NYSE.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported RBRK revenue for 2026-01-31 was $1.32B. Net income was -$348.8M. Revenue was up 48.5% from 2025-01-31 to 2026-01-31. RBRK currently screens at market cap $14.25B.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. RBRK currently screens at market cap $14.25B.
Not investment advice. Open the BSX and RBRK stock pages for the full models.
Not investment advice.